Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
258 Leser
Artikel bewerten:
(1)

Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa

Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists,along with strategic consulting expertise.

TOKYO, May 11, 2026 /PRNewswire/ -- Avalere Health, a global strategic partner for the healthcare industry, today announces the launch of its Japan office. The move marks a significant expansion of Avalere Health's global footprint, and the launch of a new strategic offering is designed to support Japanese biopharmaceutical companies end-to-end across the product lifecycle.

"The Japanese domestic drug market is witnessing explosive growth driven by oncology drugs with high demand for diabetes, immunology, and rare disease areas. These are therapeutic areas where Avalere Health has deeply entrenched expertise. Opening an office in the region is a natural progression, but more than that, it contributes to our global promise, commitment, and ability to reach every patient possible," says Amar Urhekar, CEO.

Situated in the heart of Tokyo and led by IPG veteran Junji Yokokawa, Avalere Health Japan offers a unique proposition for biopharmaceutical clients. Unlike small agencies or large network offerings, Avalere Health Japan has been perfectly formed to provide integrated solutions to healthcare's greatest challenges from day one. They will be supported by Avalere Health's global leadership team's extensive experience of building networks and agencies in the Asia-Pacific region. Urhekar spent five years as President, Japan and EVP Asia Pacific with McCann Healthcare Worldwide, as well as a further five years of senior positions within the region.

Avalere Health Japan's nimble team unite healthcare marketing, market access, and medical expertise to address the complexities of healthcare product launches in Japan. Combining deep knowledge of the Japanese landscape with global best practices, its experts support biopharmaceutical clients to navigate complex regulatory, pricing, physician, and patient engagement challenges - accelerating access, demonstrating value, and achieving stronger, more sustainable success at launch and beyond.

"I'm incredibly excited to join Avalere Health - a deeply purposeful organization with a steadfast commitment to reaching every patient possible. Japan has one of the most advanced healthcare systems in the world, a fact I'm truly proud of. However, we face immense pressures, including a rapidly aging society, financial barriers for patients, and rural access gaps. We have brought together an incredible team thoughtfully structured for collaboration with the ideal mix of expertise for both driving commercial success and making a real difference for patients across the region," says Yokokawa.

"We have carefully selected leading experts with the right mix of skills to navigate the nuanced healthcare challenges of the region, creating a team positioned to drive real change across the healthcare continuum," adds Urhekar.

The organization's approach is grounded in scientific excellence, precise execution, and culturally attuned engagement with Japanese physicians and healthcare stakeholders. By combining rigorous compliance, high-quality medical communication, and tailored omnichannel engagement, Avalere Health helps its clients maximize value, mitigate risk, and build enduring impact.

About Avalere Health

United by one profound purpose: to reach EVERY PATIENT POSSIBLE. Avalere Health ensures every patient is identified, treated, supported, and cared for. Equally.

Its Advisory, Medical, and Marketing teams come together - powerfully and intentionally - to forge unconventional connections, building a future where healthcare is not a barrier and no patient is left behind.

Avalere Health is a global strategic partner, perfectly formed to solve the biggest challenges in health-at pace and at scale. United across the product lifecycle, the organization is uniquely positioned to understand every angle of life, health, and the human condition.

Visit?www.avalerehealth.com?and follow Avalere Health on?LinkedIn.

Photo - https://mma.prnewswire.com/media/2975956/Avalere_Health_Junji_Yokokawa_and_Amar_Urhekar.jpg
Photo - https://mma.prnewswire.com/media/2975957/Avalere_Health_announces_expansion_to_Japan.jpg
Logo - https://mma.prnewswire.com/media/2088656/Avalere_Health_LogoV3_Color_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/avalere-health-expands-to-japan-with-a-full-service-advisory-medical-and-marketing-offering-led-by-industry-veteran-junji-yokokawa-302767245.html

© 2026 PR Newswire
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.